These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 6412)

  • 1. Chemical modification of streptovaricin C. II The intramolecular aldol condensation of 19-O-acetonyl-damavaricin C and its analogs.
    Sasaki K; Naito T; Satomi T; Momoki Y
    J Antibiot (Tokyo); 1976 Feb; 29(2):199-200. PubMed ID: 6412
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemical modification of streptovaricin C I. 19-O-substituted damavaricin C.
    Sasaki K; Naito T; Satomi T
    J Antibiot (Tokyo); 1976 Feb; 29(2):147-54. PubMed ID: 6410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on antimicrobial substance B 44 P (streptovaricin) produced by a strain of actinomycetes. II. Microbiological and pharmacological studies.
    Yamazaki H
    J Antibiot (Tokyo); 1968 Mar; 21(3):209-21. PubMed ID: 4386269
    [No Abstract]   [Full Text] [Related]  

  • 4. Relative biological activities of individual streptovaricins and streptovaricin acetates.
    Rinehart KL; Antosz FJ; Sasaki K; Martin PK; Maheshwari ML; Reusser F; Li LH; Moran D; Wiley PF
    Biochemistry; 1974 Feb; 13(5):861-7. PubMed ID: 4130531
    [No Abstract]   [Full Text] [Related]  

  • 5. Biological activity of damavaricin derivatives.
    Onodera K; Ito S; Sasaki K
    Subcell Biochem; 1989; 15():69-90. PubMed ID: 2572077
    [No Abstract]   [Full Text] [Related]  

  • 6. Streptovaricin U, an acyclic ansamycin.
    Knöll WM; Rinehart KL; Wiley PF; Li LH
    J Antibiot (Tokyo); 1980 Feb; 33(2):249-51. PubMed ID: 6103894
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of RNA polymerase of Escherichia coli by an antimicrobial substance B44P (streptovaricin).
    Mizuno S; Yamazaki H; Nitta K; Umezawa H
    J Antibiot (Tokyo); 1968 Jan; 21(1):66-7. PubMed ID: 4175147
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of streptovaricin on RNA synthesis in phage T4-infected Escherichia coli.
    Mizuno S; Nitta K
    Biochem Biophys Res Commun; 1969 Apr; 35(1):127-30. PubMed ID: 4388547
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies on antimicrobial substance B 44 P (streptovaricin) produced by a strain of actinomycetes. IV. Biochemical mechanism of action of substance B 44 P.
    Yamazaki H; Mizuno S; Nitta K; Utahara R; Umezawa H
    J Antibiot (Tokyo); 1968 Mar; 21(3):227-33. PubMed ID: 4386271
    [No Abstract]   [Full Text] [Related]  

  • 10. RNA polymerase mutants of Escherichia coli. I. Mutants resistant to streptovaricin.
    Yura T; Igarashi K
    Proc Natl Acad Sci U S A; 1968 Dec; 61(4):1313-9. PubMed ID: 4387741
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of focus formation of rat cells by mouse sarcoma virus by damavaricin Fc derivatives.
    Onodera K; Hiragun A; Sato M; Mitsui H; Sasaki K
    J Antibiot (Tokyo); 1979 May; 32(5):545-7. PubMed ID: 43320
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro effects of some chemotherapeutic agents on mycobacteria.
    Olitzki AL; Godinger D; Israeli M; Honigman A
    Appl Microbiol; 1967 Sep; 15(5):994-1001. PubMed ID: 4383871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of streptovaricins and their degradation products on RNA-directed DNA polymerase of Rauscher leukemia virus.
    Li LH; Cowie CH; Gray LG; Moran DM; Clark TD; Rinehart KL
    J Natl Cancer Inst; 1977 Feb; 58(2):239-43. PubMed ID: 64615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on antimicrobial substance B 44 P (streptovaricin) produced by a strain of actinomycetes. I. Production, extraction and characteristics of substance B 44 P and the identity of the substance with streptovarcin.
    Yamazaki H
    J Antibiot (Tokyo); 1968 Mar; 1(3):204-8. PubMed ID: 4386413
    [No Abstract]   [Full Text] [Related]  

  • 15. [The effect of antibiotics on the nucleic acid synthesis].
    Hartmann G; Behr W; Bock L; Honikel K; Lill H; Lill U; Sippel A
    Zentralbl Bakteriol Orig; 1970; 212(2):224-32. PubMed ID: 4392706
    [No Abstract]   [Full Text] [Related]  

  • 16. Selective inhibition of viral functions: the antiviral action of interferon and streptovaricin.
    Carter WA; Pitha P; Brockman WW; Borden EC; Marshall LW
    Medicine (Baltimore); 1972 May; 51(3):181-8. PubMed ID: 4401796
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibition of DNA-dependent RNA polymerase reaction of Escherichia coli by an antimicrobial antibiotic, streptovaricin.
    Mizuno S; Yamazaki H; Nitta K; Umezawa H
    Biochim Biophys Acta; 1968 Apr; 157(2):322-32. PubMed ID: 4384966
    [No Abstract]   [Full Text] [Related]  

  • 18. [Antimycobacterial properties of phenothiazine type compounds].
    Meindl W; Laske R
    Arch Pharm (Weinheim); 1989 Mar; 322(3):133-6. PubMed ID: 2502103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and preparation of damavaricins, biologically active precursors of streptovaricins.
    Rinehart KL; Antosz FJ; Deshmukh PV; Kakinuma K; Martin PK; Milavetz BI; Sasaki K; Witty TR; Li LH; Reusser F
    J Antibiot (Tokyo); 1976 Feb; 29(2):201-3. PubMed ID: 6413
    [No Abstract]   [Full Text] [Related]  

  • 20. The total synthesis of kanamycin A.
    Umezawa S; Tatsuta K; Koto S
    J Antibiot (Tokyo); 1968 May; 21(5):367-8. PubMed ID: 4973123
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.